UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000062383 |
|---|---|
| Receipt number | R000071326 |
| Scientific Title | Development of Fundamental Technologies for Remote Transmission of Neural Information Between Two Individuals via Information and Communication Technology |
| Date of disclosure of the study information | 2026/07/29 |
| Last modified on | 2026/07/29 13:14:26 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Development of Fundamental Technologies for Remote Transmission of Neural Information Between Two Individuals via Information and Communication Technology
Acronym
Development of Fundamental Technologies for Remote Transmission of Neural Information Between Two Individuals via Information and Communication Technology
Scientific Title
Development of Fundamental Technologies for Remote Transmission of Neural Information Between Two Individuals via Information and Communication Technology
Scientific Title:Acronym
Development of Fundamental Technologies for Remote Transmission of Neural Information Between Two Individuals via Information and Communication Technology
Region
| Japan |
Condition
Condition
healthy adults
Spinal cord injury
Stroke
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To obtain fundamental data for developing technologies that enable neural information transmission between individuals by extending computer-mediated closed-loop neural communication technologies currently implemented within a single individual.
Basic objectives2
Others
Basic objectives -Others
To verify if neural signals can be transferred via information technology between two individuals
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Operation performance of receiver device, Kinematics, EMG
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Diagnosis
Type of intervention
| Device,equipment |
Interventions/Control_1
Aritificial neural connection between two healthy individuals
Interventions/Control_2
Artificial neural connection between individuals with and without spinal cord injury
Interventions/Control_3
Artificial neural connection between individuals with and without stroke
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Individuals who voluntary control own bio-signals (e.g. EMG)
Key exclusion criteria
History of seizure or epilepsy
Pacemaker, brain surgery clip, medical pump, un-titanium metal implants
Pregnancy
Uncontrolled medical conditions
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | Yukio |
| Middle name | |
| Last name | Nishimura |
Organization
Tokyo Metropolitan Institute of Medical Science
Division name
Neural Prosthetics Project
Zip code
156-8506
Address
Kamikitazawa 2-1-6, Setagaya-ku, Tokyo, Japan
TEL
03-6834-2375
nppj@igakuken.or.jp
Public contact
Name of contact person
| 1st name | Toshiki |
| Middle name | |
| Last name | Tazoe |
Organization
Tokyo Metropolitan Institute of Medical Science
Division name
Neural Prosthetics Project
Zip code
156-8506
Address
Kamikitazawa 2-1-6, Setagaya-ku, Tokyo, Japan
TEL
03-6379-8411
Homepage URL
nppj@igakuken.or.jp
Sponsor or person
Institute
Tokyo Metropolitan Institute of Medical Science
Institute
Department
Personal name
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tokyo Metropolitan Institute of Medical Science Institutional Review Board
Address
Kamikitazawa 2-1-6, Setagaya-ku, Tokyo
Tel
03-5316-3107
hito-rinri@igakuken.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 07 | Month | 29 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2022 | Year | 08 | Month | 22 | Day |
Date of IRB
| 2022 | Year | 08 | Month | 22 | Day |
Anticipated trial start date
| 2023 | Year | 08 | Month | 04 | Day |
Last follow-up date
| 2028 | Year | 09 | Month | 04 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 07 | Month | 29 | Day |
Last modified on
| 2026 | Year | 07 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071326
